医渡科技(02158)股价今日盘中出现大涨8.25%的行情,引起了市场的广泛关注。
消息面上,据悉当前医渡科技基于 "YiduCore+DeepSeek"双引擎驱动的AI中台技术已在多家国内顶尖医疗机构深度应用,并正在进一步加速落地20余家机构,展现出在复杂医疗场景中的卓越适配能力。公司旗舰产品 YiduCore 截至上年第三季度已累计处理和分析了超过55亿份经授权医疗记录,医院网络覆盖超过2800家,疾病知识图谱覆盖所有已知疾病。
花旗银行最新研报对医渡科技给予"买入"评级,目标价上调至12港元,认为公司将充分受益于AI技术在医疗行业的广阔应用前景。该行预计,短期内 AI有望通过提高运营效率降低医疗机构员工成本;长远来看,随着 AI 技术日臻成熟,医疗 AI 市场将迎来蓬勃发展期,医渡科技凭借自主研发AI优势和行业积累将充分受益。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.